Inventor · disambiguated record
Jason Gilbert
Also filed as: GILBERT JASON · GILBERT JASON A
1 granted patent·4 pending applications·0 citations·filing 2021–2023
13Inventor score
Technology areasC12N
Files withALNYLAM PHARMACEUTICALS INC5
Top patents by PatentIndex Score
5 records- 0173US11649459B2Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 0272US2024150767A1SUPEROXIDE DISMUTASE 1 (SOD1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SUPEROXIDE DISMUTASE 1- (SOD1-) ASSOCIATED NEURODEGENERATIVE DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0355US2025283071A1Modified double stranded oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0455US2024294906A1Atxn2 irna compositions and methods of use thereof for treating or preventing atxn2-associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0550US2023126233A1LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Gilbert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →